Navigation Links
Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
Date:8/14/2009

$0.11 $0.05 $0.19 $0.08 Diluted $0.10 $0.05 $0.17 $0.07 WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic 43,527,669 42,352,139 43,289,189 42,194,048 Diluted 49,562,146 48,099,257 49,183,956 47,941,166 LOTUS PHARMACEUTICALS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) For the Six Months Ended June 30, 2009 2008 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $8,353,635 $3,176,008 Adjustments to reconcile net income from operations to net cash provided by operating activities: Depreciation and amortization 725,308 307,713 Amortization of deferred debt issuance costs 199,033 162,029 Amortization of debt discount -- 208,355 Amortization of discount on convertible redeemable preferred stock 600,669 338,838 Amortization of prepaid expense attributable to warrants 14,849 -- Stock-based compensation 109,334 270,245 Warrants revaluation -- 74,593 Decrease in allowance for doubtful accounts and sales returns -- (14,101) Recognition of unearned revenue (396,450) -- Changes in assets and liabilities: Accounts receivable 4,008,383
'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
2. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
3. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
4. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
5. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
6. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
7. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
10. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... USA (PRWEB) November 19, 2014 The ... our lives was shared with more than 200 primary ... postgraduate students from the University of Otago Physics Department ... . The Otago students, members of the university’s OSA/SPIE ... Zealand in early September, giving children from small, rural ...
(Date:11/21/2014)... The report, "Synthetic Biology Market by ... Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & ... Global Forecast to 2018", analyses and studies ... challenges. , Browse 99 market data tables ... and in-depth TOC of the global synthetic ...
(Date:11/21/2014)... November 21, 2014 2014 Deep ... Industry” is a professional and in-depth research report ... ferrocyanide information, like its definition, classification, application, ... overview. This report covers the international market analysis, ... (such as the US, Europe, Asia, China, Japan ...
(Date:11/21/2014)... and SAN DIEGO , Nov. 20, ... announced that President and CEO Marc Hedrick , M.D. will ... DATE:   Thursday, December 4, 2014 TIME:    11:15 ... here or paste this URL into your browser,s address ... investors pre-register to save time and receive event updates. ...
Breaking Biology Technology:Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4
... Pa., May 7 Encorium Group, Inc. ... multinational contract research organization (CRO) that provides design, ... patient registries to many of the world,s leading ... M.D., Ph.D. has been appointed Head Consultant of ...
... EAST BRUNSWICK, N.J., May 7 Savient Pharmaceuticals, Inc. ... biologics license application (BLA) for KRYSTEXXA (TM) (pegloticase), ... patients, will be reviewed by the Arthritis Advisory Committee ... on June 16, 2009. In December, the FDA ...
... May 7 Sigma-Aldrich Corporation (Nasdaq: SIAL ) ... Lynch 2009 Healthcare Conference on Wednesday, May 13th at 2:00 ... parties may listen via live audio broadcast over the Internet ... can click the "Webcast" icon to access this file. ...
Cached Biology Technology:Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 2Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 3Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 4Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout 2Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout 3Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout 4Sigma-Aldrich to Present at the Bank of America and Merrill Lynch 2009 Healthcare Conference on Wednesday, May 13, 2009 2
(Date:11/15/2014)... , Nov. 13, 2014  While we may still be ... McCoy used in "Star Trek" to gain instant access to ... to work with smartphones and tablets for monitoring and measuring ... healthcare world. This may seem a tad Orwellian to some, ... adopt some of these technological opportunities into their healthcare regime. ...
(Date:11/7/2014)... conjunction with the Glendale and ... the Verdugos has announced the " GLENDALE - ... to keep the Verdugo Regional Crime Lab operational after its ... existence, the Lab has processed more than 400 DNA samples, ... "Because our number one priority is the wellbeing of ...
(Date:11/6/2014)... November 6, 2014 - Insilico Medicine, Inc, a ... and age related diseases announced a research collaboration ... cancer, Champions Oncology, Inc (OTC: CSBR). , "There ... personalized medicine, but Champions Oncology,s TumorGraft technology is ... the chemotherapy regimen experimentally generating vast amounts of ...
Breaking Biology News(10 mins):Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... CHESTERFIELD, Mo. , April 22, 2013 The ... panel of experts from multiple disciplines, including farmers, media, ... questions surrounding GMOs. This discussion was moderated by CNBC ... The Food Dialogues℠: Chicago , which ...
... checked were for native Australian millipede species and were published ... and the Atlas of Living Australia , ALA. GBIF ... but disclaim any responsibility for errors in museum databases, instead ... fit for purpose. The auditing was done voluntarily by ...
... April 2013. Researchers have known for some years that the ... Arctic when the waters in its traditional habitat become too ... are now moving up as far as Spitsbergen into the ... two and a half years, biologists from the Alfred Wegener ...
Cached Biology News:CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago 2CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago 3Online biodiversity databases audited: 'Improvement needed' 2Atlantic cod in for even more stress? 2Atlantic cod in for even more stress? 3
Component of HyperMu™ Insertion Kit...
...
Request Info...
... Rabbits x 2 , ... bleed x1 /each , Immunizations/Boost injections ... (app. 5 ml) x1 /each , ... /each , Final Bleed ~ 100 ml blood ...
Biology Products: